BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 21922273)

  • 21. Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.
    Zhu J; Reith ME
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):393-409. PubMed ID: 19128199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residues of ractopamine, a livestock feed additive, in meat might alleviate misuse of cocaine, nicotine, methamphetamine, and morphine.
    Fan FS
    Nutr Health; 2023 Jun; 29(2):171-174. PubMed ID: 36266952
    [No Abstract]   [Full Text] [Related]  

  • 23. Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats.
    Jadzic D; Bassareo V; Carta AR; Carboni E
    Addict Biol; 2021 Jan; 26(1):e12864. PubMed ID: 31849152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of cocaine and methamphetamine consumption and preference in Drosophila melanogaster.
    Highfill CA; Baker BM; Stevens SD; Anholt RRH; Mackay TFC
    PLoS Genet; 2019 May; 15(5):e1007834. PubMed ID: 31107875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.
    Gonzalez S; Fernandez-Ruiz J; Sparpaglione V; Parolaro D; Ramos JA
    Drug Alcohol Depend; 2002 Mar; 66(1):77-84. PubMed ID: 11850139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacological basis of drug dependence.
    Marlow HF
    S Afr Med J; 1970 May; 44(21):610-5. PubMed ID: 4316744
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research.
    Anker JJ; Carroll ME
    Neurosci Biobehav Rev; 2010 Nov; 35(2):315-33. PubMed ID: 20398693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptations in adenosine signaling in drug dependence: therapeutic implications.
    Hack SP; Christie MJ
    Crit Rev Neurobiol; 2003; 15(3-4):235-74. PubMed ID: 15248812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans-generational effects of parental exposure to drugs of abuse on offspring memory functions.
    Riyahi J; Taslimi Z; Gelfo F; Petrosini L; Haghparast A
    Neurosci Biobehav Rev; 2024 May; 160():105644. PubMed ID: 38548003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.
    Pistis M; Perra S; Pillolla G; Melis M; Muntoni AL; Gessa GL
    Biol Psychiatry; 2004 Jul; 56(2):86-94. PubMed ID: 15231440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.
    Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
    Psychopharmacology (Berl); 2022 May; 239(5):1211-1230. PubMed ID: 34613429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of serotonin in drug use and addiction.
    Müller CP; Homberg JR
    Behav Brain Res; 2015 Jan; 277():146-92. PubMed ID: 24769172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.
    Eiden LE; Weihe E
    Ann N Y Acad Sci; 2011 Jan; 1216():86-98. PubMed ID: 21272013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of exposure to addictive drugs on future generations: Physiological and behavioral effects.
    Vassoler FM; Byrnes EM; Pierce RC
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):269-75. PubMed ID: 23810828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug addiction.
    Camí J; Farré M
    N Engl J Med; 2003 Sep; 349(10):975-86. PubMed ID: 12954747
    [No Abstract]   [Full Text] [Related]  

  • 37. Cannabinoid-induced alterations in brain disposition of drugs of abuse.
    Reid MJ; Bornheim LM
    Biochem Pharmacol; 2001 Jun; 61(11):1357-67. PubMed ID: 11331071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial infections, immunomodulation, and drugs of abuse.
    Friedman H; Newton C; Klein TW
    Clin Microbiol Rev; 2003 Apr; 16(2):209-19. PubMed ID: 12692094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of L-type Ca(v)1 channels in the development of psychological dependence.
    Shibasaki M; Kurokawa K; Ohkuma S
    Synapse; 2010 Jun; 64(6):440-4. PubMed ID: 20169575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adolescent drug exposure: A review of evidence for the development of persistent changes in brain function.
    Salmanzadeh H; Ahmadi-Soleimani SM; Pachenari N; Azadi M; Halliwell RF; Rubino T; Azizi H
    Brain Res Bull; 2020 Mar; 156():105-117. PubMed ID: 31926303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.